Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Biosoftware, Celera Genomics, AnaSpec

Rosetta Biosoftware has formed a scientific advisory board to provide guidance for the development and commercialization of proteomic products, the company announced.
The board will consist of Reudi Aebersold, Ronald Hendrickson, and Yoshiya Oda.
Aebersold is a professor at the Swiss Institute of Technology and the University of Zurich. He is also a co-founder and current faculty member of the Institute for Systems Biology in Seattle.
Hendrickson is the director of proteomics in the department of molecular profiling at Merck Research Laboratories. Before joining Merck, he contributed “to expanding large scale protein-protein interaction studies using yeast as a model organism” at MDS Proteomics, now called Protana, Rosetta said.
Oda is a senior scientist at the Laboratory of Seeds Finding Techology, Tokyo-based Eisai, and a visiting associate professor at the Metabolome Laboratory, Graduate School of Medicine at the University of Tokyo. He also developed a widely used method of metabolic labeling for quantitative proteomics, Rosetta said.

Celera Genomics Group has appointed Joel Jung as vice president of finance effective immediately, the company said this week. Most recently Jung was vice president and treasurer at Chiron where he was responsible for that company’s global treasury and risk-management function, the corporate tax department and the corporate finance analytical group, Celera said.
Jung has a BA from Purdue University and an MBA from the University of California, Berkeley

Rich Meyer has joined AnaSpec as R&D manager where he will responsible for the product development strategy of the company’s detection reagents and kits division.
Meyer joins AnaSpec from Invitrogen where he was director of global chemistry and acting director for R&D for the molecular probes subsidiary. Meyer received his PhD in chemistry from the University of California, Santa Barbara.
AnaSpec provides proteomic solutions to pharmaceutical firms, biotech companies and academic institutions and focuses on three core technologies, peptides, detection reagents and combinatorial chemistry, the company said.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.